Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 3.51 USD 4.46% Market Closed
Market Cap: 199.3m USD
Have any thoughts about
Design Therapeutics Inc?
Write Note

Wall Street
Price Targets

DSGN Price Targets Summary
Design Therapeutics Inc

Wall Street analysts forecast DSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSGN is 7.48 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
44% Upside
Average
Price Target
7.48 USD
113% Upside
Highest
Price Target
12.6 USD
259% Upside
Design Therapeutics Inc Competitors:
Price Targets
RNAC
Cartesian Therapeutics Inc
289% Upside
GNFT
Genfit SA
156% Upside
BSLN
Basilea Pharmaceutica AG
104% Upside
603087
Gan & Lee Pharmaceuticals
22% Upside
SNDX
Syndax Pharmaceuticals Inc
292% Upside
PEB
Pacific Edge Ltd
17% Downside
PHM
Pharma Mar SA
17% Upside
CRNX
Crinetics Pharmaceuticals Inc
148% Upside

Revenue
Forecast

Revenue Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DSGN's stock price target?
Price Target
7.48 USD

According to Wall Street analysts, the average 1-year price target for DSGN is 7.48 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Back to Top